ClinVar Miner

Submissions for variant NM_000551.3(VHL):c.463+4C>T (rs879253989)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000679042 SCV000293080 uncertain significance not provided 2016-07-14 criteria provided, single submitter clinical testing This variant is denoted VHL c.463+4C>T or IVS2+4C>T and consists of a C>T nucleotide substitution at the +4 position of intron 2 of the VHL gene. Multiple in silico models predict that this variant has no effect on gene splicing; however, in the absence of RNA or functional studies, the actual effect of this variant is unknown. This variant has not, to our knowledge, been published in the literature. However, a different nucleotide change at this same position, VHL c.463+4C>G, has been demonstrated to segregate with hemangioblastoma and pheochromocytoma in at least one family and to cause aberrant splicing via RT-PCR (Sexton 2015). VHL c.463+4C>T was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The cytosine (C) nucleotide that is altered is conserved across species. Based on currently available information, it is unclear whether VHL c.463+4C>T is pathogenic or benign. We consider it to be a variant of uncertain significance.
Invitae RCV000560865 SCV000626905 uncertain significance Erythrocytosis, familial, 2; Von Hippel-Lindau syndrome 2017-08-03 criteria provided, single submitter clinical testing
PreventionGenetics,PreventionGenetics RCV000679042 SCV000805350 likely benign not provided 2018-01-02 criteria provided, single submitter clinical testing
Ambry Genetics RCV001022813 SCV001184592 uncertain significance Hereditary cancer-predisposing syndrome 2019-12-20 criteria provided, single submitter clinical testing Insufficient evidence

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.